Advanced Enzymes Technologies’ board has approved the investment of an amount not exceeding Rs 316.26 million by way of subscription to the issue of 492,630 equity shares of SciTech Specialties (SSPL), as may be offered on preferential issue / private placement basis by SSPL and purchase of 27,778 from selling shareholders of SSPL, aggregating to 520,408 equity shares i.e. 51% of equity share capital of SSPL and authorization for signing of Share Subscription and Shareholders' Agreement in this regard. On completion of the aforesaid investment, SSPL will become subsidiary of the company. The Board of Directors of the company in its meeting held on December 26, 2020 has approved the same.
Advanced Enzymes Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.10 |
Dr. Reddys Lab | 1352.75 |
Cipla | 1510.25 |
Lupin | 2367.85 |
Zydus Lifesciences | 975.55 |
View more.. |